🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

MRKR MRKR

Company Profile ↓
$1.14
-8.06% 1Y
P/E-1.44
52W High$2.19
52W Low$0.85
EPS (TTM)$-0.79

Company Overview

MRKR (MRKR) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Growth & Price Performance

Stock Price Performance

1 Year:-8.06%
6 Months:-38.38%
3 Months:-24.50%
1 Month:-32.14%
Technical Snapshot Bearish
52-Week Range 22% of range
$0.85 $2.19
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • Death Cross6d ago
  • RSI (14)36.34 · Neutral
Price Performance
1M-32.14%
3M-24.50%
6M-38.38%
1Y-8.06%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 48.0% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-1.44
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-
Earnings (YoY)
-

Profitability & Returns

ROCE
-74.05%
ROE
-72.42%
ROA
-63.78%
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.16
EPS (TTM)
$-0.79

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$17.43M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
5.49%
Chg in Prom Hold
-
FII / Inst Holding
23.71%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$0
EBITDA
$-12.44M
Free Cash Flow
$-18.66M
Operating Cash Flow
$-12.01M
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2013Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue -------------0183.06K-205.99K0-00-------------------
Operating Income --675.13K-313.29K----1.03M-1.14M-1.74M-1.75M-2.43M-2.72M-2.42M-2.39M-3.99M-3.20M-4.67M-4.43M-5.64M-5.87M-5.65M-6.64M-6.36M-7.38M-8.78M-10.91M-10.02M-9.79M-5.27M-5.83M-4.31M-4.13M-3.20M-2.55M-2.31M-2.40M-4.96M-4.26M-2.14M-4.07M
Net Income -1.08M-870.80K--29.71M753.48K-1.57M-700.72K-60.22M28.50M-4.75M5.97M-2.10M-2.42M-1.89M-3.99M-3.20M-4.81M-4.39M-5.32M-5.57M-5.46M-6.49M-6.34M-7.37M-8.78M-10.91M-12.43M-9.91M-9.24M-6.92M-4.97M2.52M-2.98M-2.39M-2.19M-2.31M-4.45M-4.02M-2.00M-3.18M
Diluted EPS ------0.09--1.804.23-0.35-0.29--0.22-0.39----------0.16-0.13-0.15-1.19-1.11-0.83-0.570.29-0.34-0.27-0.25-0.26-0.40-0.29-0.12-0.16
R&D Expense 242.98K54.40K30.00K22.50K22.50K32.50K609.38K201.16K968.76K985.75K1.25M1.11M989.09K1.20M1.62M1.60M1.83M1.88M2.83M3.15M3.12M3.82M4.28M4.80M5.64M7.35M6.78M7.03M2.92M3.59M3.38M2.38M2.04M2.58M2.34M3.47M3.14M4.18M2.35M2.84M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2000Dec 2001Dec 2002Dec 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -----------------183.06K205.99K213.19K500.00K-03.31M00
Cost of Revenue --------------------------
Gross Profit --------------------------
Operating Expenses ----------------------19.79M14.58M11.12M12.44M
Operating Income -----------5.47M-3.32M--2.66M-3.37M-6.16M-8.49M-11.48M-148.17M-22.53M-28.89M--19.79M-11.27M-11.12M-12.44M
EBITDA -----------------------19.79M-11.27M-11.12M-12.44M
Interest Expense --------------------------
Pretax Income -----------------------19.78M-10.73M-10.68M-12.18M
Tax Provision ----------------------03.67K49.95K-15.16K
Net Income -935.33K-671.99K-2.28M-5.78M-2.68M-985.60K-1.30M-3.89M-2.20M-17.35M-3.53M-2.03M-5.86M-5.53M-30.88M-34.07M-2.46M-10.98M-147.96M-21.43M-28.71M--29.93M-8.24M-10.73M-12.16M
Diluted EPS ----------------9.30-0.72-1.16---0.61--3.58-0.94-1.19-0.79
R&D Expense ----------290.05K203.72K1.06M697.63K189.00K1.71M3.80M5.25M7.95M12.76M18.88M27.79M11.97M10.42M13.47M11.80M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 1999Dec 2000Dec 2001Dec 2002Dec 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -----------116.43K307.92K104.21K--6.65M7.92M5.18M62.14M46.36M45.61M68.14M34.42M17.13M22.02M19.07M
Total Equity 100.37K252.23K-74.05K465.83K-643.75K-2.44M-2.22M-3.00M-1.67M-3.02M-1.78M-3.87M-3.46M-6.04M-8.77M-1.02M-21.36M6.18M3.66M59.34M44.09M27.34M43.99M19.60M14.05M18.56M16.80M
Cash & Equivalents ------------------5.13M61.75M43.90M21.35M42.35M11.78M15.11M19.19M16.07M
Total Liabilities -----------------1.74M1.52M2.80M2.27M18.27M24.15M14.82M3.07M3.46M2.27M
Current Liabilities -----------3.98M3.80M5.77M8.85M1.25M28.01M1.74M1.52M2.80M1.99M6.40M12.90M7.78M3.07M3.46M2.27M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -925.04K-1.31M--694.58K-2.19M-4.34M-6.51M-8.44M-14.48M-18.28M-20.03M-27.28M-26.97M-16.44M-10.91M-12.01M
Investing Cash Flow -------0-147.67K-374.98K-9.25M-3.13M-4.95M18.66M--
Financing Cash Flow 807.13K1.54M1.37M709.33K2.28M10.78M7.78M5.72M71.25M816.48K6.74M52.56M202.13K1.11M14.99M9.86M
Capital Expenditure --------0-147.67K-374.98K------
Free Cash Flow --------8.44M-14.63M-18.66M------
Share Buybacks ------0310.49K71.71K-------

Ratios (Annual)

Figures in %.

Metric Dec 2000Dec 2001Dec 2002Dec 2003Dec 2004Dec 2005Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --------------------------
Operating Margin % ------------------6,271.1%-71,930.1%-10,567.3%-5,777.2%---340.4%--
Net Margin % ------------------5,999.1%-71,826.3%-10,050.9%-5,741.2%---248.8%--
ROE % -370.8%907.5%-490.5%897.7%110.0%44.4%43.5%232.4%72.6%973.0%91.4%58.6%96.9%63.1%3,017.0%159.5%-39.7%-300.2%-249.3%-48.6%-105.0%--152.7%-58.6%-57.8%-72.4%
ROCE % ----------141.5%94.9%---28.8%-137.3%-313.8%-249.7%-50.8%-73.7%--74.3%-80.2%-59.9%-74.0%

Shareholding Pattern

Insiders
5.49%
Institutions
23.71%
Public Float
25.09%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MRKR

Google News Wed, 18 Mar 2026

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPOFkwNTJOenA0STZFTndDejV0VEZPQUtjR0FIVUxQOHhCc24zaEFROW03bzRUcVEyWWFiYnA5YWxpZUpEWlpuUG9BNE1hVGdkRUZGVFhxTXY3REMwcjNhVmxFck43SmtKUXdfdDAzZ19FcGFrU3RYRTdLejBPTkVFSFJwM1puSzU1Y196Qk…

Google News Fri, 26 Jun 2026

MRKR Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE1ldDhuRkFtVi01MG1DS3kyN2p1ajc4NDVzeFdnR0s4eHRPaFlCX1lLeUhpRXJmaUVXV1N5dnZJYzFkSWVUWnd0YUpBTDI4cGlYMUFvZEdqZ2pZdEVuNnlpWGpGRzZPMWxpUkpnb2M1anlRLVBtS3VHczZR?oc=5" target="_blank">MRK…

Google News Fri, 31 Jul 2026

MRKR|Marker Therapeutics Inc|Price:1.235|Chg%:+0.105 - TradingKey

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE4zTVVPVTRzOWlEZ19TRkppTV9lcUpVX2VBaFJIYzVHLXpQTWRhTGh0OUJNOWwybVgyc2RaTV9zeVNJTjdnVUxURDk4SlhNNFAtcWo2SXBNdmhTTi1rNFNWaFFpREFNM3daMXBMWTZR?oc=5" target="_blank">MRKR|Marker Therape…

Google News Mon, 12 Jan 2026

Here's Why We're Watching Marker Therapeutics' (NASDAQ:MRKR) Cash Burn Situation - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxNeGkyQlNZbHpqQjIwMDNZYUxEY1ZtZktnaW5SNnJqTEJ3UjhYMy1PNV9qT1MzUWVjWnFjVkF5NHI3ZzExc2EwNDVnOTJRbXhGdm1pYWpYZ3A3ejZ1aGV1c1lFSE10V1BXY0FLX2RhMjRXQ0FyVFo4RlRRRVlsZ2pXNTU5dkVVaWJDZmV6N0…

Google News Wed, 18 Mar 2026

Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results - GlobeNewswire

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQYVBxRklTQTQ1eG9YM1ZsdTlucFRNODZLTGhUbzZCOXJhamozUFFSeHhhN0NQLV9fTFoxbHh1bHpjT1FpQjZFc1NCaDB4dVVsQTNpOVEwWTNudFR5clZvdmo3X2dCdWJTZDV1RDluNzIwUTRaTzRETGRWVGNIN0lQb3RENGRXX1VfR05tYj…

Google News ue, 28 Jul 2026

Marker Therapeutics, Inc. Revenue Breakdown – NASDAQ:MRKR - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBzZGQ2RVhGc1NFU2xVZ244SFF4aGo0NFppRXpMTWYtYW0yakduWEZad21BdXhtdlpyV2JEVENmLVJsWHA1WVNVR2NmM25GRHlWczlmb3ktejJEQmpDTjFDV2FkeFotVDJ4bEFXR3pUSDhCVnlvYlJr?oc=5" target="_blank">Marker …

MRKR — Frequently Asked Questions

What is the current share price of MRKR?

As of 2026-08-05 17:25 PDT, MRKR trades at $1.14 on NASDAQ/NYSE. Its 52-week range is $0.85 to $2.19.

What is the P/E ratio of MRKR?

MRKR trades at a trailing price-to-earnings (P/E) ratio of -1.44.

What is the return on equity (ROE) of MRKR?

MRKR has a return on equity (ROE) of -72.42%. Its return on capital employed (ROCE) is -74.05%.

Is MRKR a good stock to buy?

This page provides a data-driven analysis of MRKR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space